Another Common Herbicide Linked to Cancer

<a href="http://www.shutterstock.com/cat.mhtml?lang=en&language=en&ref_site=photo&search_source=search_form&version=llv1&anyorall=all&safesearch=1&use_local_boost=1&autocomplete_id=143509768245718090000&searchterm=pesticides&show_color_wheel=1&orient=&commercial_ok=&media_type=images&search_cat=&searchtermx=&photographer_name=&people_gender=&people_age=&people_ethnicity=&people_number=&color=&page=1&inline=226389340" target="_blank">Tom Grundy</a>/Shutterstock

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Less than three months after declaring that the ubiquitous herbicide glyphosate, marketed by Monsanto as Roundup, is “probably carcinogenic,” a working group of scientists convened by the World Health Organization has taken aim at another widely used herbicide, 2,4-D, which the WHO panel has found to be “possibly carcinogenic.”

These announcements can hardly be welcome news in the Midwest, whose farm fields are blanketed in corn and soybeans. Since the advent of crops genetically engineered to withstand glyphosate in the 1990s, farmers there have come to rely heavily on the herbicide that many weed varieties have evolved to resist, causing many headaches and a surge in herbicide use.

This past spring, Dow Chemical introduced new genetically modified corn and soybean products designed to solve that problem. They’re engineered to resist not just glyphosate, but also, you guessed it, 2,4-D. And Dow is selling farmers a proprietary herbicide known as Enlist Duo, a combo of glyphosate and 2,4-D, that farmers can apply directly to the crops grown from the new genetically modified corn and soybean seeds. As I’ve shown before, these double-herbicide-resistant crops will likely accelerate, not solve, the resistant-weed problem.

Even so, rather than filling their spray tanks solely with a “probable” carcinogen, corn and soybean farmers can now fill up with a mix of “possible” and “probable” carcinogens before spraying their fields. That may sound like a twisted form of progress, but it should be noted that there’s evidence that toxic chemicals do worse things to us when combined than they do solo. That such “synergistic” effects are little studied is hardly comforting.

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate